Preliminary reports on interleukin-2 offer hope for better control of the HIV virus.
Murphy
M J
MJ
LSU School of Medicine, USA.
D002455:Cell Division / Q000187:drug effects; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000502:physiology; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000166:cytology / Q000187:drug effects; D017735:Virus Latency
D007376:Interleukin-2